期刊文献+

吡柔比星通过PLCε-Bcl-2通路抑制膀胱癌细胞增殖 被引量:2

Pirarubicin inhibits proliferation of bladder cancer cells through PLCε-Bcl-2 pathway
原文传递
导出
摘要 目的探讨吡柔比星对膀胱癌细胞增殖的影响及其作用机制。方法膀胱癌细胞T24和BIU-87分别用0.4、0.8、1.6、3.2mg/L的吡柔比星处理24、48、72h,用四甲基偶氮唑盐(MTT)检测细胞增殖,流式细胞术检测细胞凋亡率,qRT-PCR、RT-PCR检测磷脂酶Cε(PLCε)mRNA及凋亡调控基因Bcl-2mRNA的表达,蛋白质印迹法检测PLCε蛋白的表达。将膀胱癌细胞分为空白组、吡柔比星处理组、Ad-shPLCε处理组、吡柔比星联合PLCε干扰腺病毒载体(Ad-shPLCε)处理组,检测并比较各组细胞增殖和Bcl-2蛋白的表达量。结果在膀胱癌细胞T24、BIU-87中,吡柔比星对细胞的抑制率呈浓度、时间依赖性,即随着药物浓度增加、处理时间延长,细胞抑制率升高;吡柔比星促进T24和BIU-87细胞凋亡,并且抑制PLCε和Bcl-2表达。吡柔比星处理组、Ad-shPLCε处理组、Ad-shPLCε联合吡柔比星处理组均能抑制细胞增殖和Bcl-2表达,且Ad-shPLCε联合吡柔比星处理组的抑制作用高于吡柔比星处理组,差异有统计学意义(P<0.05)。结论吡柔比星能有效抑制膀胱癌细胞的增殖,可能与其抑制PLCε癌基因及下游Bcl-2基因的表达有关。 Objective To investigate the effects of pirarubicin on proliferation of bladder cancer cells and the related mechanism.Methods After bladder cancer cell lines T24 and BIU-87 were treated with 0.4,0.8,1.6,and 3.2mg/L pirarubicin for 24,48,and 72h,the cell proliferation was detected by MTT.Flow cytometry was used to examine the apoptosis of T24 and BIU-87 cells.qRT-PCR and RT-PCR were used to examine the mRNA expression of phospholipase Cε(PLCε),Bcl-2in T24 and BIU-87 cell lines;the protein expression of PLCεin pirarubicin-treated cells was determined by Western blotting analysis.Bladder cancer cells were designed as blank group,pirarubicin treatment group,Ad-shPLCεtreatment group,and Ad-shPLCεplus pirarubicin treatment group;cell proliferation was observed and protein expression of Bcl-2 was examined and compared between different groups.Results Pirarubicin showed a dose- and time-dependent inhibitory effect against proliferation of T24 and BIU-87 cell lines.Moreover,pirarubicin promoted cell apoptosis in T24 and BIU-87 cells and suppressed the expression of PLCεand Bcl-2.Pirarubicin treatment group,Ad-shPLCεtreatment group,and Ad-shPLCεplus pirarubicin treatment group all had suppressed cell proliferation and Bcl-2expression,and pirarubicin plus Ad-shPLCεgroup exhibited significantly stronger inhibitory effects compared with pirarubicin treatment group(P0.05).Conclusion Pirarubicin can effectively inhibit cell proliferation of bladder cancer cells,which may be through suppressing the expression of PLCεand Bcl-2.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2014年第7期708-713,共6页 Academic Journal of Second Military Medical University
基金 国家自然科学基金(81072086) 重庆市教委科学技术研究项目(KJ110305)~~
关键词 吡柔比星 磷脂酶Cε BCL-2 膀胱肿瘤 细胞增殖 pirarubicin phospholipase C epsilon Bcl-2 bladder neoplasms cell proliferation
  • 相关文献

参考文献16

  • 1Siegel R, Naishadham D, Jemal A. Cancer statistics [J]. CA Cancer J Clin,2013,63..11-30.
  • 2Chamie K, Litwin M S, Bassett J C, Daskivich T J, Lai J, Hanley J M, et al. Recurrence of high risk bladder cancer : a population-based analysis [J]. Cancer, 2013, 119:3219 -3227.
  • 3陈忠,李家贵,叶章群,杨为民,张旭,曾晓勇.联合灌注预防浅表性膀胱肿瘤术后复发的临床观察[J].肿瘤防治研究,2005,32(2):108-109. 被引量:7
  • 4魏辉,梅骅.表浅膀胱癌的膀胱灌注疗法[J].临床泌尿外科杂志,2003,18(9):565-566. 被引量:23
  • 5Kawano H, Komaba S, Yamasaki T, Maeda M, Kimura Y, Maeda A, et al. New potential therapy for orthotopic bladder carcinoma by combining HVJ envelope with doxorubicin [J]. Cancer Chemother Pharmacol, 2008, 61 :973-978.
  • 6Song C, Hu C D, Masago M, Kariyai K, Yamawaki- Kataoka Y, Shibatohge M, et al. Regulation of a novel human phospholipase C: PLC epsilon through mem- brane targeting by Ras [J]. J Biol Chem, 2001,276: 2752-2757.
  • 7Bai Y, Edamatsu H, Maeda S, Saito H, Suzuki N, Satoh T, et al. Crucial role of phospholipase C epsilon in chemical carcinogen-induced skin tumor development [J]. Cancer Res,2004,64: 8808-8810.
  • 8Li M, Edamatsu H, Kitazawa R, Kitazawa S, Katao- ka T. Phospholipase C epsilon promotes intestinal tu- morigenesis of Apc (Min/+) mice through augmenta- tion of inflammation and angiogenesis[J]. Carcinogene- sis,2009,30 : 1424-1432.
  • 9张彦懿,欧俐苹,刘琪,陶佳,吴小侯,罗春丽.PLCε基因shRNA重组腺病毒表达质粒的构建及鉴定[J].中国生物制品学杂志,2013,26(1):51-55. 被引量:2
  • 10Ikuta S, Edamatsu H, Li M, Hu L, Kataoka T. Crucial role of phospholipase C epsilon in skin inflammation in- duced by tumor-promoting phorbol ester [J]. Cancer Res,2008,68:64- 72.

二级参考文献29

  • 1杨金龙 韩家娴 沈祖铭 等.羟基喜树碱对体外培养人体胃腺癌细胞(SGC-7901)增殖和TdR掺入DNA的影响.肿瘤,1982,2(1):21-23.
  • 2Nomata K, Noguchi M, Kanetake H, et al. Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: results of a randomized trial with epirubicin comparing short-term versus long-term maintenance treatment[J]. Cancer Chemother Pharmacol, 2002,50 (4): 266-270.
  • 3Chu XY,Suzuki H,Ueda K,et al.Active effectof CPT-11 and its Metabolitesin human KB-derived cell lines[J].J Pharmacol Exp Ther,1999,288(2):735-741.
  • 4Kaufmann SH. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note[J]. Cancer Res, 1989,49(21 ): 5870-5878.
  • 5Song C, Hu C D, Masago M,et al. Regulation of a novel human phospholipase C, PLCepsilon, through membrane targeting by Ras [ J ]. Biol Chem,2001,276(4) :2752-2757.
  • 6Lopez I, Mak E C, Ding J,et al. A novel bifunctional phospholipase C that is regulated by gα12 and stimulates the ras/mitogen-actived protein kinase pathway [ J ]. Biol Chem ,2001,4 (276) :2758-2765.
  • 7Kelly G G, Reks S E, Ondrako J M, et al. Phospholipase Cε: a novel Ras effector[ J ]. EMBO,2001,4(20) :743-754.
  • 8Song C, Satoh T, Edamatsu H, et al. Differential roles of Ras and Rapl in growth factor-dependent activation of phospholipase Cε[ J ]. Oncogene ,2002,21 (53) :8105-8113.
  • 9Varga A,Czifra G,Tallai B,et al. Tumor grade-dependent alterations in the protein kinase C isform pattern in urinary bladder carcinomas [J ]. Eur Urol,2004,46(4) :462-465.
  • 10Bai Y F, Hironori E, Sakan M,et al. Crucial role of phospholipase Cε in chemical carcinogen-induced skin tumor development cancer[ J]. Research ,2005,64:8808-8810.

共引文献37

同被引文献28

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部